Introducing Sodium Phenylbutyrate prepared to the Buphenyl standard—a potent ammonia scavenger designed to reduce hyperammonemia in patients with urea cycle disorders. This formulation facilitates alternative nitrogen excretion, thereby improving metabolic balance and preventing neurotoxicity associated with urea cycle defects. Experience enhanced clinical outcomes, reduced ammonia levels, and improved cognitive function with this advanced, targeted tablet therapy.